Detalles de la búsqueda
1.
Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Int J Cancer
; 142(9): 1911-1925, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29235112
2.
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Int J Cancer
; 141(3): 594-603, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28480996
3.
CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Int J Cancer
; 138(1): 171-81, 2016 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26178914
4.
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts.
Radiother Oncol
; 191: 110055, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109944
5.
Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer Patients.
Cancers (Basel)
; 15(19)2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835591
6.
microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
Blood
; 115(21): 4191-7, 2010 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-20089965
7.
Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy.
Radiother Oncol
; 171: 91-100, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429503
8.
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy.
Radiother Oncol
; 167: 300-307, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34999136
9.
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT.
Cancers (Basel)
; 14(12)2022 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740697
10.
Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Cancer Immunol Immunother
; 60(1): 75-85, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20857100
11.
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.
Eur J Cancer
; 158: 17-26, 2021 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638090
12.
2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma.
Sci Rep
; 10(1): 15625, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32973220
13.
Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC.
Cancers (Basel)
; 12(10)2020 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33086761
14.
Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.
J Mol Med (Berl)
; 86(5): 541-52, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18297255
15.
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy.
Clin Cancer Res
; 24(6): 1364-1374, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29298797
16.
Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
Radiother Oncol
; 127(1): 27-35, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29295747
17.
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
Radiother Oncol
; 126(1): 125-131, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061496
18.
A role of TRAIL in killing osteoblasts by myeloma cells.
FASEB J
; 20(6): 759-61, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16436464
19.
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling.
Sci Rep
; 7(1): 13206, 2017 10 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038455
20.
SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy.
Clin Transl Radiat Oncol
; 5: 28-36, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29594214